Ex­clu­sive: San Diego biotech rais­es $11.7M to use cells as tar­get­ed de­liv­ery ves­sels for ge­net­ic med­i­cines

Cy­tonus Ther­a­peu­tics, a small biotech com­pa­ny north of San Diego, raised $11.7 mil­lion in Se­ries A fi­nanc­ing to en­gi­neer cells as de­liv­ery ves­sels for ge­net­ic med­i­cines, in­clud­ing mR­NA ther­a­pies and on­colyt­ic virus­es for can­cer, End­points News has learned.

The un­con­ven­tion­al ap­proach flips the script on cell ther­a­py. Rather than us­ing the cell as a med­i­cine it­self, a par­tial­ly-gut­ted cell trans­ports a drug to a spec­i­fied ad­dress in the body, thanks to mol­e­c­u­lar hom­ing bea­cons ap­pend­ed to its sur­face.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER